NEURACLE SCIENCE CO.
Latest round
- Series C
Last raised
- Jun 2019
Total raised
- $33M
Investors
- 9
About NEURACLE SCIENCE CO.
Founded in 2015 and based in Seoul, South Korea, NEURACLE SCIENCE CO. LTD operates as a biopharmaceutical company that develops pharmaceutical treatments of neurodegenerative diseases. NEURACLE SCIENCE CO. LTD develops treatments for severe neurological disorders such as Alzheimer’s disease, Parkinson’s disease, and neurogenic bowel dysfunction. The company’s research includes candidates like NS101, an antibody currently in clinical development for Alzheimer’s disease and other neurodegenerative conditions, and NS200, which targets colonic motility disorders and neurogenic bowel dysfunction. Their development pipeline also features advanced antibody therapeutics, utilizing proprietary Fc Engineering to enhance drug efficacy. These solutions aim to improve nerve regeneration, synapse formation, and neural environment remodeling.
Who invested in NEURACLE SCIENCE CO.
9 investors across 2 rounds
See all investors in NEURACLE SCIENCE CO.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about NEURACLE SCIENCE CO.
Who invested in NEURACLE SCIENCE CO.?
NEURACLE SCIENCE CO. has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NEURACLE SCIENCE CO. raised?
NEURACLE SCIENCE CO. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did NEURACLE SCIENCE CO. last raise money?
NEURACLE SCIENCE CO.'s most recent round on record is a Series C, in Jun 2019.
What does NEURACLE SCIENCE CO. do?
Founded in 2015 and based in Seoul, South Korea, NEURACLE SCIENCE CO.
Where is NEURACLE SCIENCE CO. headquartered?
NEURACLE SCIENCE CO. is headquartered in Seoul, South Korea.
Which VCs invest in companies like NEURACLE SCIENCE CO.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at NEURACLE SCIENCE CO.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like NEURACLE SCIENCE CO.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.